Treatment with angiotensin II in COVID-19 patients may not be beneficial

類似資料

• Treatment with angiotensin II in COVID-19 patients may not be beneficial
  著者:: Susanne Rysz, 等
  出版事項: (2020-09-01)
• COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
  著者:: Rysz, Susanne, 等
  出版事項: (2021)
• Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery
  著者:: Eriksson, Karin E., 等
  出版事項: (2021)
• Characteristics and outcomes of patients with COVID‐19 admitted to ICU in a tertiary hospital in Stockholm, Sweden
  著者:: Larsson, Emma, 等
  出版事項: (2020)
• The Use of Levosimendan after Out-of-Hospital Cardiac Arrest and Its Association with Outcome—An Observational Study
  著者:: Susanne Rysz, 等
  出版事項: (2022-05-01)